Sensex 27629.11 122.4 (0.44%)29-May-15 09:45
Nifty 8353.1 34.1 (0.41%)29-May-15 09:34
India Infoline News Service | Mumbai May 29, 2015 07:48 IST
The results which are expected today are Sun Pharmaceutical Industries, Glenmark Pharmaceuticals,Jet Airways, Indian Oil Corporation, Cipla, Bosch, IL... Read more
The decline in topline extended for the tenth consecutive quarter for BHEL, largely due to shrinking... >>
JSPL’s consolidated revenue was lower by 11.3% on a yoy basis to Rs. 4,526cr as contribution from ... >>
Healthy revenue and margin traction yoy... >>
|Sector||Mcap (Rs.Cr)||Up / Down Chg (%)|
|IT - Software||11,21,756.67||63.41 / 36.59|
|Banks||10,93,854.15||40.00 / 60.00|
|Pharmaceuticals||6,04,726.98||62.03 / 37.97|
|Refineries||5,22,890.19||75.00 / 25.00|
|Automobile||5,11,685.87||68.75 / 31.25|
|Finance||4,97,014.67||59.72 / 40.28|
|Crude Oil & Natural Gas||4,86,225.46||57.14 / 42.86|
|FMCG||4,28,665.87||75.86 / 24.14|
|Mining & Mineral products||3,97,321.39||47.06 / 52.94|
|Power Generation & Distribution||3,61,530.81||37.50 / 62.50|
|Tobacco Products||2,88,056.92||50.00 / 50.00|
GETTING REAL FM aims to lower fiscal deficit with a minimal increase in tax rate....
When I was in school, bureaucracy, or getting a job in the government especially the IAS was the Dream Job...
Planning for retirement is no longer solely about the mandatory PF and Pension calculations done in the fag-end years of employment or busin...
|Scheme Name||NAV(Rs.)||1w %||3m %||6m %||1y %||3y %|
|Birla Sun Life MNC Fund - Direct (G)||582.7||[0.21]||1.64||21.25||75.72||0|
|SBI Small & Midcap Fund - Direct (G)||30.36||[1.90]||0.38||16.60||74.13||0|
|Birla Sun Life MNC Fund - B (G)||573.02||[0.23]||1.39||20.66||74.08||37.09|
|Sundaram Select Micro Cap - Sr.IV - Direct (G)||22.41||[0.13]||[1.46]||11.77||73.32||0|
|SBI Small & Midcap Fund (G)||29.71||[1.93]||0.02||15.82||71.97||42.50|
“Future investments will be in consolidation and growth of existing business vertical, including execution capabilities, opening offices i...
"We expect to see a reasonable step-up in growth in FY16, with further acceleration in FY17, as both global and domestic companies execute t...